Events like the Social Summit in Porto Must Address the Social Determinants of Health

07 May 2021

The key to addressing non-communicable diseases like diabetes lies in eliminating social inequalities.

The Diabetes epidemic is pervasive. In 2019, 59 million adults in Europe were living with diabetes and this figure is forecasted to rise to 66 million by 2030. This has and will have wide-ranging ramifications for society at large. Diabetes-related costs account for around 9% of total health expenditure (approx. €100 billion per annum), 75% of which is due to preventable complications. Diabetes reduces the life expectancy of people aged 40-60 by 4-10 years and is causally linked to other non-communicable diseases such as cancer and cardiovascular disease. Additionally, in 2015 people living with diabetes accounted for the third-largest number of potentially avoidable hospitable bed days spent in Europe, among all the major chronic diseases.

Institutions Enter Trilogues on Health Technology Assessment

03 May 2021

With both the Council and the Parliament securing their negotiating mandates, the first trilogue on the Health Technology Assessment (HTA) Regulation was scheduled to take place at the end of April.

Trials@Home Biannual meeting Brings Together 31 Project Partners to Discuss the Future of Clinical Trials in Europe

30 April 2021

With COVID-19 continuing to disrupt our lives and limiting people’s movements, carrying out clinical trials has been particularly challenging over the past year. This comes on top of the hurdles typically faced in traditional trials, especially regarding participant recruitment and retention.